(Q46885628)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18034421%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

title

Selective silencing of DNA-specific B lymphocytes delays lupus activity in MRL/lpr mice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18034421%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18034421%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Bor-Luen Chiang

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18034421%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

author name string

Andrey I Tchorbanov

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18034421%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Elisaveta N Voynova

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18034421%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Nikolina M Mihaylova

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18034421%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Todor A Todorov

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18034421%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Vihra M Yomtova

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18034421%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Tchavdar L Vassilev

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18034421%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

language of work or name

English

0 references

publication date

1 December 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18034421%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Immunology

27 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18034421%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

volume

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18034421%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18034421%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

page(s)

3587-3596

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18034421%20AND%20SRC:MED&resulttype=core&format=json

Molecular analysis of the autoantibody response in peptide-induced autoimmunity

27 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737143

Alpha-actinin is a cross-reactive renal target for pathogenic anti-DNA antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737143

Systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737143

7 January 2021

A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737143

7 January 2021

From T to B and back again: positive feedback in systemic autoimmune disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737143

7 January 2021

Prevention of autoimmune symptoms in autoimmune-prone mice by elimination of B-1 cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737143

7 January 2021

B-cell targeting in rheumatoid arthritis and other autoimmune diseases

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737143

7 January 2021

Workshop report on some new ideas about the treatment of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737143

7 January 2021

Successful long-term treatment of systemic lupus erythematosus with rituximab maintenance therapy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737143

7 January 2021

LJP 394 for the prevention of renal flare in patients with systemic lupus erythematosus: results from a randomized, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737143

7 January 2021

Genetic and structural evidence for antigen selection of anti-DNA antibodies.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737143

7 January 2021

Autoimmune NZB/NZW F1 mice utilize B cell receptor editing for generating high-affinity anti-dsDNA autoantibodies from low-affinity precursors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737143

7 January 2021

Breaking of tolerance to native DNA in nonautoimmune mice by immunization with natural protein/DNA complexes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737143

7 January 2021

Negative signaling in Fc receptor complexes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737143

7 January 2021

Immune inhibitory receptors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737143

7 January 2021

Fcgamma receptors: old friends and new family members

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737143

7 January 2021

Pathology and protection in nephrotoxic nephritis is determined by selective engagement of specific Fc receptors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737143

7 January 2021

Augmented humoral and anaphylactic responses in Fc gamma RII-deficient mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737143

7 January 2021

Genetic modifiers of systemic lupus erythematosus in FcgammaRIIB(-/-) mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737143

7 January 2021

Selective dysregulation of the FcgammaIIB receptor on memory B cells in SLE

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737143

7 January 2021

Treatment with dsDNA-anti-dsDNA antibody complexes extends survival, decreases anti-dsDNA antibody production and reduces severity of nephritis in MRLlpr mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737143

7 January 2021

Peptide mimicking antigenic and immunogenic epitope of double-stranded DNA in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737143

7 January 2021

Epitope mapping of new monoclonal antibodies recognizing distinct human FcRII (CD32) isoforms.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737143

7 January 2021

Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737143

7 January 2021

Short-lived plasmablasts and long-lived plasma cells contribute to chronic humoral autoimmunity in NZB/W mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737143

7 January 2021

Development of Autoantibodies before the Clinical Onset of Systemic Lupus Erythematosus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737143

7 January 2021

Variable regions of antibodies to synthetic polypeptides--I. Characterization of an idiotope expressed on antibodies and T-cell factors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737143

7 January 2021

Preparative reversed-phase liquid chromatography of peptides. Isocratic two-step elution system for high loads on analytical columns

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737143

7 January 2021

[7] The use of carbodiimides in the preparation of immunizing conjugates

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737143

7 January 2021

Immunity and protection against influenza virus by synthetic peptide corresponding to antigenic sites of hemagglutinin

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737143

7 January 2021

The inhibitory Fcγ receptor modulates autoimmunity by limiting the accumulation of immunoglobulin G+ anti-DNA plasma cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200737143

7 January 2021